• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经母细胞瘤中1p36的详细分子分析。

Detailed molecular analysis of 1p36 in neuroblastoma.

作者信息

White P S, Thompson P M, Seifried B A, Sulman E P, Jensen S J, Guo C, Maris J M, Hogarty M D, Allen C, Biegel J A, Matise T C, Gregory S G, Reynolds C P, Brodeur G M

机构信息

Division of Oncology, Children's Hospital of Philadelphia, Pennsylvania 19104-4318, USA.

出版信息

Med Pediatr Oncol. 2001 Jan;36(1):37-41. doi: 10.1002/1096-911X(20010101)36:1<37::AID-MPO1010>3.0.CO;2-L.

DOI:10.1002/1096-911X(20010101)36:1<37::AID-MPO1010>3.0.CO;2-L
PMID:11464901
Abstract

BACKGROUND

Several lines of evidence es tablish that chromosome band 1p36 is frequently deleted in neuroblastoma primary tumors and cell lines, suggesting that a tumor suppressor gene within this region is involved in the development of this tumor.

PROCEDURE

We analyzed the status of 1p36 in primary neuroblastomas and cell lines to define the region of consistent rearrangement.

RESULTS

Loss of heterozygosity (LOH) studies of primary neuro blastomas identified allelic loss in 135 of 503 tumors (27%), with the smallest region of overlap (SRO) defined distal to D15214 (1p36.3). No homozygous deletions were detected at 120 loci mapping to 1p36.1-p36.3 in a panel of 46 neuroblastoma cell lines. A recently identified patient with neuroblastoma was found to have a constitutional deletion within 1p36.2-p36.3, and this deletion, when combined with the LOH results, defined a smaller SRO of one megabase within 1p36.3. We constructed a comprehensive integrated map of chromosome 1 containing 11,000 markers and large-insert clones, a high-resolution radiation hybrid (RH) map of 1p36, and a P1-artificial chromosome (PAC) contig spanning the SRO, to further characterize the region of interest. Over 768 kb (75%) of the SRO has been sequenced to completion. Further analysis of distal 1p identified 113 transcripts localizing to 1p36, 21 of which were mapped within the SRO.

CONCLUSION

This analysis will identify suitable positional candidate transcripts for mutational screening and subsequent identification of the 1p36.3 neuroblastoma suppressor gene.

摘要

背景

多项证据表明,染色体1p36区在神经母细胞瘤原发肿瘤和细胞系中经常发生缺失,提示该区域内的一个肿瘤抑制基因参与了此肿瘤的发生发展。

方法

我们分析了原发神经母细胞瘤和细胞系中1p36的状态,以确定一致重排的区域。

结果

对原发神经母细胞瘤的杂合性缺失(LOH)研究发现,503例肿瘤中有135例(27%)存在等位基因缺失,最小重叠区域(SRO)定位于D15214(1p36.3)远端。在一组46个神经母细胞瘤细胞系中,映射到1p36.1 - p36.3的120个位点未检测到纯合缺失。发现一名新诊断的神经母细胞瘤患者在1p36.2 - p36.3区域存在先天性缺失,将此缺失与LOH结果相结合,确定了1p36.3内一个较小的1兆碱基SRO。我们构建了包含11,000个标记和大插入片段克隆的1号染色体综合整合图谱、1p36的高分辨率辐射杂种(RH)图谱以及跨越SRO的P1人工染色体(PAC)重叠群,以进一步表征感兴趣的区域。SRO超过768 kb(75%)已完成测序。对1p远端的进一步分析确定了113个转录本定位于1p36,其中21个映射在SRO内。

结论

该分析将确定合适的位置候选转录本用于突变筛查以及随后鉴定1p36.3神经母细胞瘤抑制基因。

相似文献

1
Detailed molecular analysis of 1p36 in neuroblastoma.神经母细胞瘤中1p36的详细分子分析。
Med Pediatr Oncol. 2001 Jan;36(1):37-41. doi: 10.1002/1096-911X(20010101)36:1<37::AID-MPO1010>3.0.CO;2-L.
2
Smallest region of overlapping deletion in 1p36 in human neuroblastoma: a 1 Mbp cosmid and PAC contig.人类神经母细胞瘤中1p36区域最小重叠缺失区域:一个1兆碱基的黏粒和噬菌体人工染色体重叠群。
Genes Chromosomes Cancer. 2001 Jul;31(3):228-39. doi: 10.1002/gcc.1139.
3
Comprehensive analysis of chromosome 1p deletions in neuroblastoma.神经母细胞瘤中1p染色体缺失的综合分析。
Med Pediatr Oncol. 2001 Jan;36(1):32-6. doi: 10.1002/1096-911X(20010101)36:1<32::AID-MPO1009>3.0.CO;2-0.
4
Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours.1p36.2 - 3区域肿瘤抑制候选基因区域的精细定位,该区域在神经母细胞瘤和生殖细胞肿瘤中常发生缺失。
Med Pediatr Oncol. 2001 Jan;36(1):61-6. doi: 10.1002/1096-911X(20010101)36:1<61::AID-MPO1016>3.0.CO;2-0.
5
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.胶质瘤中1p36和19q13的等位基因缺失:与组织学分类的相关性、1p36上150kb最小缺失区域的定义以及CAMTA1作为候选肿瘤抑制基因的评估
Clin Cancer Res. 2005 Feb 1;11(3):1119-28.
6
An integrated 5-Mb physical, genetic, and radiation hybrid map of a 1p36.1 region implicated in neuroblastoma pathogenesis.一个与神经母细胞瘤发病机制相关的1p36.1区域的5兆碱基物理、遗传和辐射杂种综合图谱。
Genes Chromosomes Cancer. 2000 Feb;27(2):143-52.
7
Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma.神经母细胞瘤中持续缺失的1p36.3区域的定义与特征
Oncogene. 2005 Apr 14;24(16):2684-94. doi: 10.1038/sj.onc.1208306.
8
Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1.1号染色体短臂部分缺失的神经母细胞瘤的生物学特征
Med Pediatr Oncol. 2001 Jan;36(1):67-74. doi: 10.1002/1096-911X(20010101)36:1<67::AID-MPO1017>3.0.CO;2-S.
9
Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.神经母细胞瘤中CDKN2A(p16INK4a/p14ARF)存在纯合缺失,但1p36区域或其他肿瘤抑制基因座无此情况。
Cancer Res. 2001 Jan 15;61(2):679-86.
10
Identification and characterization of novel genes located at the t(1;15)(p36.2;q24) translocation breakpoint in the neuroblastoma cell line NGP.
Genomics. 2000 Mar 1;64(2):195-202. doi: 10.1006/geno.1999.6097.

引用本文的文献

1
Gene utility recapitulates chromosomal aberrancies in advanced stage neuroblastoma.基因效用概括了晚期神经母细胞瘤中的染色体异常。
Comput Struct Biotechnol J. 2022 Jun 20;20:3291-3303. doi: 10.1016/j.csbj.2022.06.024. eCollection 2022.
2
Targeting lipid metabolism in cancer: neuroblastoma.针对癌症中的脂质代谢:神经母细胞瘤
Cancer Metastasis Rev. 2022 Jun;41(2):255-260. doi: 10.1007/s10555-022-10040-8.
3
MYCN amplification plus 1p36 loss of heterozygosity predicts ultra high risk in bone marrow metastatic neuroblastoma.
MYCN 扩增加上 1p36 杂合性丢失预测骨髓转移性神经母细胞瘤的超高风险。
Cancer Med. 2022 Apr;11(8):1837-1849. doi: 10.1002/cam4.4583. Epub 2022 Feb 9.
4
From DNA Copy Number Gains and Tumor Dependencies to Novel Therapeutic Targets for High-Risk Neuroblastoma.从DNA拷贝数增加和肿瘤依赖性到高危神经母细胞瘤的新型治疗靶点
J Pers Med. 2021 Dec 3;11(12):1286. doi: 10.3390/jpm11121286.
5
CHD5 inhibits metastasis of neuroblastoma.CHD5 抑制神经母细胞瘤的转移。
Oncogene. 2022 Jan;41(5):622-633. doi: 10.1038/s41388-021-02081-0. Epub 2021 Nov 17.
6
Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma.卡利林-RAC 控制 ADRN 型神经母细胞瘤的核迁移。
Life Sci Alliance. 2021 Mar 3;4(5). doi: 10.26508/lsa.201900332. Print 2021 May.
7
Developing preclinical models of neuroblastoma: driving therapeutic testing.开发神经母细胞瘤的临床前模型:推动治疗测试。
BMC Biomed Eng. 2019 Dec 20;1:33. doi: 10.1186/s42490-019-0034-8. eCollection 2019.
8
Large 1p36 Deletions Affecting Arid1a Locus Facilitate Mycn-Driven Oncogenesis in Neuroblastoma.大片段 1p36 缺失影响 ARID1A 基因座,促进神经母细胞瘤中 MYCN 驱动的肿瘤发生。
Cell Rep. 2020 Jan 14;30(2):454-464.e5. doi: 10.1016/j.celrep.2019.12.048.
9
Systematic computational identification of prognostic cytogenetic markers in neuroblastoma.系统计算鉴定神经母细胞瘤中的预后细胞遗传学标志物。
BMC Med Genomics. 2019 Dec 12;12(1):192. doi: 10.1186/s12920-019-0620-6.
10
Research progress of neuroblastoma related gene variations.神经母细胞瘤相关基因变异的研究进展
Oncotarget. 2017 Mar 14;8(11):18444-18455. doi: 10.18632/oncotarget.14408.